White Paper

Drug Safety And Product Protection Driving Blister Packaging Growth

Source: Ropack Pharma Solutions

By Yves Massicotte, President, Ropack Pharma Solutions

blisterpack

Trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market. This escalation outpaces the growth of other packaging formats, principally bottling. While key factors driving that trend reflect the ongoing focus by manufacturers on drug safety and protection, others arise from the latest government regulations and the growing voice of the consumer.

A recent survey of pharmaceutical professionals, selected by an industry-focused media group, measured and compared buying behavior for blister vs. bottle pharmaceutical packaging. When asked to show a preference of blister over bottle, 44.7% showed a preference for blister by responding that they would “always” or “frequently” choose blister over bottle. On the other hand, 29.1% showed a preference for bottle packaging by saying they would “never” or “rarely” choose blister over bottle.

VIEW THE WHITE PAPER!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader